WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007095613) USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES AS NEUROPROTECTIVE AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/095613    International Application No.:    PCT/US2007/062232
Publication Date: 23.08.2007 International Filing Date: 15.02.2007
IPC:
C07D 209/14 (2006.01), C07D 309/34 (2006.01), C07D 333/54 (2006.01), C07D 409/12 (2006.01), A61K 31/343 (2006.01), A61K 31/38 (2006.01), A61K 31/404 (2006.01), A61P 25/28 (2006.01)
Applicants: JANSSEN PHARMACEUTICA N.V. [BE/BE]; TURNHOUTSEWEG 30, B-2340 Beerse (BE) (For All Designated States Except US).
SMITH-SWINTOSKY, Virginia L. [US/US]; (US) (For US Only)
Inventors: SMITH-SWINTOSKY, Virginia L.; (US)
Agent: JOHNSON, Philip S.; Johnson & Johnson, One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (US)
Priority Data:
60/773,725 15.02.2006 US
11/673,987 12.02.2007 US
Title (EN) USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES AS NEUROPROTECTIVE AGENTS
(FR) UTILISATION DE DERIVES DE BENZO-HETEROARYL SULFAMIDE EN TANT QU'AGENTS NEUROPROTECTEURS
Abstract: front page image
(EN)The present invention is a methods for neuroprotection, for treating an acute neurodegenerative disorder, for treating a chronic neurodegenerative disorder and / or for preventing neuron death or damage following brain, head and / or spinal cord trauma or injury comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I).
(FR)La présente invention concerne des procédés de neuroprotection, destinés à traiter les troubles neurodégénératifs aigu, chronique et/ou à prévenir la mort neuronale ou des dommages consécutifs à un traumatisme ou à une lésion cérébral, crânien et/ou de la moelle épinière, comprenant l'administration à un sujet en ayant besoin d'une quantité thérapeutiquement efficace d'un ou de plusieurs dérivés de benzo-hétéroaryl sulfamide répondant à la formule (I) telle qu'elle est définie dans le présent document.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)